Generic Drugs Face New Tariff Shock | Panama City Beach News

Starting August 28, a 100% tariff on imported generic drugs is set to hit, rising to 200% by 2029 — a bold move aimed at forcing manufacturers to bring production back to the U.S. With most generics currently made overseas, this could make them cost nearly as much as brand-name drugs, already facing tariffs. Industry players are calling for clearer policy details while pushing for solutions to keep medicines affordable and accessible. Meanwhile, the U.S. is eyeing Germany’s pricing model and recently struck a deal with the UK to exempt their drugs — in exchange for higher prices. The global tug-of-war over drug pricing and trade is heating up, with major implications for Americans’ wallets and national security. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6316102257c3f4d4